Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy aims to cut blood transfusions in bone tumor surgery

NCT ID NCT07314424

First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 25 times

Summary

This study looks at whether giving a combination of intravenous iron, erythropoietin (EPO), and tranexamic acid before surgery can improve anemia and reduce the need for blood transfusions in people with bone tumors. About 160 adults with low iron or hemoglobin levels who are scheduled for open surgery on the spine, pelvis, or sacrum will take part. The goal is to see if this approach helps patients recover better and avoid blood shortages.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.